While mycophenolate mofetil is standard of care treatment for lupus nephritis, belimumab might be an alternative.

Deucravacitinib reduces circulating proteins associated with kidney dysfunction in patients with systemic lupus erythematosus, according to data presented at ACR Convergence 2025.“Specific plasma ...

Falls are common among adults with SLE and are linked to several factors, including higher disease activity, organ damage, and polypharmacy.

Lupus is notorious for its unpredictable symptoms, which can vary significantly from person to person. Some of the most common symptoms include: Fatigue: A feeling of overwhelming tiredness that does ...

The recent passing of singer Selena has shocked fans and friends alike, highlighting the serious impact of lupus, a chronic autoimmune disease. This article explores the implications of lupus, the ...

The Lupus Foundation of America (LFA) proudly presented eight abstracts and sessions during the 2025 American College of Rheumatology (ACR) Convergence with the goal of advancing science, improving ...

Although overall mortality rates for patients with lupus have declined since the turn of the century, racial, sex and ...

Phase I/II data for rese-cel point to its therapeutic potential in systemic lupus erythematosus and lupus nephritis, as well ...

Gazyva/Gazyvaro versus mycophenolate mofetil shows significantly more children and young adults achieved sustained complete ...

C HICAGO -- People who died with systemic lupus erythematosus (SLE) were far more likely than car crash victims to have ...

The current recommended urine protein to creatinine ratio is arbitrary, and a lower bar would capture more lupus nephritis ...